Why, how and in whom should we measure levels of lipoprotein(a): A review of the latest evidence and clinical implications

Documenti analoghi

• A review of the latest real‐world evidence studies in diabetic kidney disease: What have we learned about clinical practice and the clinical effectiveness of interventions?
  di: Fabrice Bonnet, et al.
  Pubblicazione: (2024)
• The latest evidence and clinical guidelines for use of meal replacements in very‐low‐calorie diets or low‐calorie diets for the treatment of obesity
  di: Shenelle A. Edwards‐Hampton, et al.
  Pubblicazione: (2024)
• Associations of intra‐pancreatic fat deposition with triglyceride‐rich lipoproteins and lipoprotein lipase
  di: Yutong Liu, et al.
  Pubblicazione: (2025)
• The latest evidence and guidance in lifestyle and surgical interventions to achieve weight loss in people with overweight or obesity
  di: Iskandar Idris, et al.
  Pubblicazione: (2025)
• Coronary artery disease risk prediction by combined stratification of low‐density lipoprotein‐cholesterol and high‐density lipoprotein‐cholesterol levels across different glucose statuses
  di: Junko Yachida, et al.
  Pubblicazione: (2024)